Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Bean bonanza: study reveals which beans are best for your belly!

NCT ID NCT06935435

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how different kinds of beans (like pink, great northern, and a mix) change the bacteria in your gut and affect your health. Researchers will compare these beans in 12 adults, some with obesity and some without. The goal is to learn which bean types are best for gut health, blood pressure, and digestion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 19 to 50 years. 2. Not currently pregnant or planning to become pregnant (Females Only). 3. Stable body mass index (BMI) of either 18.5-24.9 kg/m2 or 27.0-39.9 kg/m2 for the last month. 4. Has not made any major dietary changes in the last month. 5. Able to read and speak English 6. Requires no legally authorized representative (LAR). 7. Not institutionalized (e.g., prison, psychological treatment center, etc.). 8. Able to wear ambulatory blood pressure monitor and limit physical activity over a 24-hr. period. 9. Have a bowel movement at least every other day. 10. Able to collect and deliver stool samples to Innovation Campus within 4 hours of collection. 11. No known allergies or intolerance to beans. 12. Able to avoid consuming beans during the study, except for the provided beans (up to 1.5 cups/day). Exclusion Criteria: 1. Has a cardiac device. 2. History of organ transplant 3. History of gastrointestinal surgery or disease diagnosed by a physician that involves the stomach, small, and large intestines (e.g., IBD, IBS, chronic constipation, diverticulosis, gastric bypass). 4. Recent history of cancer (excluding skin cancer) in the last year. 5. Current use of tobacco or vaping. 6. Current or recent use (last 3 weeks) of digestive enzymes, laxatives, dietary fiber, prebiotic, or probiotic supplements. 7. Medication or supplement regimen or dosage changed within the last 2 months or 3 weeks, respectively. 8. Taken antibiotics in the last 2 months. 9. Known allergies or intolerances to beans. 10. BMI 18.5-24.9 kg/m2 (normoweight): Current use of oral or injectable medications for the treatment of most chronic conditions. 11. BMI 27.0-39.9 kg/m2 (overweight): Current use of oral or injectable medications for the treatment of diabetes, hypertension, cardiovascular, liver, kidney, gastrointestinal, or autoimmune.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dietary intervention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nebraska Food for Health Center

    Lincoln, Nebraska, 68588, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.